GS-4497, an inhibitor of apoptosis signal-regulating kinase (ASK1), alone or in combination with simtuzumab for the treatment of nonalcoholic steatohepatitis (NASH): a randomized, phase 2 trial - Loomba, R; Lawitz, E; Mantry, P S (AASLD Liver Meeting, 2016)